Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data
Generic Name : Ponatinib
Indication : Chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (CML) in adult patients who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib & for w...
Manufacturer : Otsuka
Generic Name : Ibrutinib
Indication : As a single agent for the treatment of adult patients w/ relapsed or refractory mantle cell lymphoma. As a single agent or in combination w/ rituximab or obinutuzumab for the treatment of adult patien...
Manufacturer : Janssen
Generic Name : durvalumab
Indication : Treatment of patients w/ unresectable stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy & radiation therapy. In combina...
Manufacturer : AstraZeneca
Distributor : Four Star / Zuellig
Generic Name : Gefitinib
Indication : Monotherapy for the treatment of adults w/ locally advanced or metastatic NSCLC w/ activating mutations of epidermal growth factor receptor tyrosine kinase (EGFR-TK).
Manufacturer : AstraZeneca
Distributor : Four Star / Zuellig
Generic Name : Ruxolitinib
Indication : Disease-related splenomegaly or symptoms in adults w/ primary myelofibrosis (MF) (chronic idiopathic MF), post polycythaemia vera (PV) MF or post essential thrombocythaemia MF. PV in adults who are re...
Manufacturer : Novartis
Distributor : Four Star / Zuellig
Related Diseases

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in